Vapotherm, a company based in New Hampshire, has released the latest version of its Precision Flow Hi-VNI system. The system is used to deliver non-invasive ventilation to spontaneously breathing patients using the company’s Mask-Free NIV technology.
The latest version of the system features updated hardware and software, which purportedly improves on reliability and “to comply with the EMC 4th Edition requirements for medical devices, IEC 60601-1-2:2014,” according to a Vapotherm press release.
Precision Flow Hi-VNI uses a nasal cannula, instead of a face mask, to deliver warm, humidified gas at high velocity to the patient. The patient can talk, eat, and feel a lot more comfortable than being restricted by a breathing mask.
Some more details from Vapotherm:
In 2018, the U.S. Food and Drug Administration (FDA) granted the Precision Flow Hi-VNI system a new product category and product code (QAV). The FDA also granted an expanded indication for the system that states it may be used to augment breathing of spontaneously breathing patients suffering from respiratory distress in a hospital setting. This patient population is similar to that treated by other forms of non-invasive ventilation, making the Precision Flow Hi-VNI system a viable alternative to Non-invasive Positive Pressure Ventilation (NiPPV) for most patients.